4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001737287-23-000004
EVP of R&D acquired 251,908 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Roberts Zachary · EVP of R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-20 | Grant or award : show line 1 in the form | +251,908 | 251,908 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-20 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +873,015 | 873,015 | D |
Loading xslF345X03/primary_doc.xml…